Literature DB >> 17594944

Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.

Pierre Palmer1, Michael G Tovey, Franck Raschilas, Lilia Brassart, Jean-François Meritet, Raphaël Porcher, Pierre Lebon.   

Abstract

Through the activation of Toll-like receptors (TLRs) or cytosolic RNA helicases, a large number of pathogenic or synthetic components can induce the transcription of genes coding for type I interferons (IFNs). This family of related cytokines includes notably, a single IFN-beta protein and 13 different IFN-alpha subtypes, whose biological activities are probably not the same. The aim of this study was to characterize the type I IFN subtypes produced in vitro by human peripheral blood mononuclear cells (PBMCs) in response to specific inducers. Thus, PBMCs obtained from a single donor, were exposed to various agents including Sendai virus, Herpes simplex virus-1 (HSV-1), poliovirus-IgG complexes and serum from a patient with systemic lupus erythematosus (SLE). Six hours later, mRNA was extracted and amplified by RT-PCR using primers which recognize IFN-B mRNA and the different IFN-A mRNA subtypes. IFN-A subtypes were identified by cloning and sequencing the amplification product. Antiviral activity was assayed in supernatant at 18 hours. Human PBMCs were found to express constitutively type I IFNs mRNA. Antiviral activity and expression of IFN-A and IFN-B mRNA increased with each inducing agent. Although almost all the IFN-A subtypes were detected, their relative abundance appeared to be dependent upon the inducing agent. Incubation of PBMCs with a neutralizing monoclonal antibody directed against the type I IFN receptor (IFNAR) did not affect the level of antiviral activity in the supernatant of induced PBMCs. Our results suggest that the level of IFN-alpha expressed by PBMCs cells is independent of IFNAR feedback signalling and that the nature of the inducing agent modifies the pattern of IFN-A subtypes preferentially expressed by these cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594944     DOI: 10.1684/ecn.2007.0093

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  10 in total

1.  Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Authors:  Maja Markušić; Maja Šantak; Tanja Košutić-Gulija; Mladen Jergović; Renata Jug; Dubravko Forčić
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

2.  Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells.

Authors:  Richard Szubin; W L William Chang; Tamara Greasby; Laurel Beckett; Nicole Baumgarth
Journal:  J Interferon Cytokine Res       Date:  2008-12       Impact factor: 2.607

Review 3.  Targeting interferons in systemic lupus erythematosus: current and future prospects.

Authors:  Alexis Mathian; Miguel Hie; Fleur Cohen-Aubart; Zahir Amoura
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

4.  Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.

Authors:  Luna A Zaritsky; Jacquelyn R Bedsaul; Kathryn C Zoon
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

Review 5.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

6.  Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.

Authors:  Ousmane M Diop; Mickaël J-Y Ploquin; Lorenzo Mortara; Abdourahmane Faye; Béatrice Jacquelin; Désirée Kunkel; Pierre Lebon; Cécile Butor; Anne Hosmalin; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

7.  Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

Authors:  Gillian I Rice; Gabriella M A Forte; Marcin Szynkiewicz; Diana S Chase; Alec Aeby; Mohamed S Abdel-Hamid; Sam Ackroyd; Rebecca Allcock; Kathryn M Bailey; Umberto Balottin; Christine Barnerias; Genevieve Bernard; Christine Bodemer; Maria P Botella; Cristina Cereda; Kate E Chandler; Lyvia Dabydeen; Russell C Dale; Corinne De Laet; Christian G E L De Goede; Mireia Del Toro; Laila Effat; Noemi Nunez Enamorado; Elisa Fazzi; Blanca Gener; Madli Haldre; Jean-Pierre S-M Lin; John H Livingston; Charles Marques Lourenco; Wilson Marques; Patrick Oades; Pärt Peterson; Magnhild Rasmussen; Agathe Roubertie; Johanna Loewenstein Schmidt; Stavit A Shalev; Rogelio Simon; Ronen Spiegel; Kathryn J Swoboda; Samia A Temtamy; Grace Vassallo; Catheline N Vilain; Julie Vogt; Vanessa Wermenbol; William P Whitehouse; Doriette Soler; Ivana Olivieri; Simona Orcesi; Mona S Aglan; Maha S Zaki; Ghada M H Abdel-Salam; Adeline Vanderver; Kai Kisand; Flore Rozenberg; Pierre Lebon; Yanick J Crow
Journal:  Lancet Neurol       Date:  2013-10-30       Impact factor: 44.182

8.  Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha.

Authors:  Manamita Mandal; Rina Tripathy; Aditya K Panda; Sarit S Pattanaik; Simanchal Dakua; Anjan Kumar Pradhan; Soumen Chakraborty; Balachandran Ravindran; Bidyut K Das
Journal:  Arthritis Res Ther       Date:  2014-02-10       Impact factor: 5.156

9.  Detection of interferon alpha protein reveals differential levels and cellular sources in disease.

Authors:  Mathieu P Rodero; Jérémie Decalf; Vincent Bondet; David Hunt; Gillian I Rice; Scott Werneke; Sarah L McGlasson; Marie-Alexandra Alyanakian; Brigitte Bader-Meunier; Christine Barnerias; Nathalia Bellon; Alexandre Belot; Christine Bodemer; Tracy A Briggs; Isabelle Desguerre; Marie-Louise Frémond; Marie Hully; Arn M J M van den Maagdenberg; Isabelle Melki; Isabelle Meyts; Lucile Musset; Nadine Pelzer; Pierre Quartier; Gisela M Terwindt; Joanna Wardlaw; Stewart Wiseman; Frédéric Rieux-Laucat; Yoann Rose; Bénédicte Neven; Christina Hertel; Adrian Hayday; Matthew L Albert; Flore Rozenberg; Yanick J Crow; Darragh Duffy
Journal:  J Exp Med       Date:  2017-04-18       Impact factor: 14.307

10.  Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.

Authors:  Chiraz Hamimi; Annie David; Pierre Versmisse; Laurence Weiss; Timothée Bruel; David Zucman; Victor Appay; Arnaud Moris; Marie-Noëlle Ungeheuer; Caroline Lascoux-Combe; Françoise Barré-Sinoussi; Michaela Muller-Trutwin; Faroudy Boufassa; Olivier Lambotte; Gianfranco Pancino; Asier Sáez-Cirión
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.